| Attribute | Value |
|----------|-------|
| Symbol | DYNC2H1 |
| Name | Dynein Cytoplasmic 2 Heavy Chain 1 |
| Chromosome | 11q22.3 |
| NCBI Gene ID | 1771 |
| UniProt ID | Q8IVD4 |
| Ensembl ID | ENSG00000130938 |
| Gene Type | Protein-coding |
| Aliases | DYH1, HL12, DYHC2, DNCH2, DHC2 |
DYNC2H1 (Dynein Cytoplasmic 2 Heavy Chain 1) encodes the heavy chain of cytoplasmic dynein-2, a motor protein complex involved in intracellular transport, retrograde axonal transport, and the function of cilia and flagella. Dyneins are members of the ATPase protein family that move along microtubules toward their minus ends, transporting cargo from the cell periphery toward the cell center. This gene is essential for proper neuronal function and has been implicated in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic Lateral Sclerosis (ALS).
Cytoplasmic dynein-2 (also known as dynein-2) is distinct from cytoplasmic dynein-1, which is the primary motor for retrograde transport in neurons. While dynein-1 is well-studied in neurodegeneration, dynein-2 has unique functions in intracellular trafficking that are relevant to neuronal health and disease.
DYNC2H1 encodes the cytoplasmic dynein 2 heavy chain 1, a microtubule motor protein that powers minus-end-directed intracellular transport along microtubule tracks. Dyneins are among the largest and most complex molecular motors, functioning as the primary retrograde transport system in eukaryotic cells. The heavy chain contains the motor domain that hydrolyzes ATP to generate force for cargo movement toward the minus end of microtubules (toward the cell center).
The dynein motor complex consists of multiple subunits:
- Heavy chains: Motor activity (DYNC2H1 is the key heavy chain)
- Intermediate chains: Cargo binding and regulation
- Light chains: Various regulatory functions
- Light intermediate chains: Cargo adaptor interactions
Dynein-mediated transport is fundamental to neuronal health. Neurons have extremely long axons requiring efficient transport systems to move cargo between the cell body and synaptic terminals. DYNC2H1 dysfunction contributes to neurodegeneration through:
- Retrograde transport impairment: Reduced transport of signaling endosomes, organelles, and recycling vesicles
- Axonal swellings: Accumulation of organelles and transport intermediates
- Synaptic dysfunction: Impaired delivery of synaptic proteins and organelles to nerve terminals
DYNC2H1 plays a critical role in intraflagellar transport (IFT), the process by which protein complexes are transported bidirectionally along the axoneme of cilia and flagella. IFT is essential for:
- Cilium assembly: Building and maintaining ciliary structure
- Ciliary membrane protein trafficking: Transporting proteins to the ciliary membrane
- Signal transduction: Moving signaling components to cilia
- Retrograde transport: Carrying cargo from the ciliary tip back to the cell body
The IFT system operates through:
- Anterograde transport: IFT-B complex moved by kinesin-2 toward ciliary tip
- Retrograde transport: IFT-A complex moved by dynein-2 (DYNC2H1) toward ciliary base
This bidirectional transport is essential for maintaining ciliary homeostasis and function.
Cilia are membrane-bound organelles that extend from the cell surface and perform diverse functions:
- Sensory cilia: Detect chemical and mechanical signals
- Motile cilia: Generate fluid flow
- Primary cilia: Coordinate signaling pathways (Shh, Wnt, PDGFRα)
DYNC2H1 localizes to the ciliary tip, axoneme, and ciliary base, participating in both motile and non-motile cilium assembly. The protein is essential for:
- Ciliary length control
- Ciliary membrane protein composition
- Ciliary signaling platform formation
In Alzheimer's disease (AD), dynein function is compromised through multiple mechanisms:
- Amyloid-β effects: Amyloid-β oligomers can impair dynein function
- Tau pathology: Hyperphosphorylated tau disrupts microtubule-based transport
- Dysfunction of signaling: Reduced retrograde signaling from synapses to cell bodies
The failure of dynein-mediated transport contributes to:
- Synaptic loss
- Somal degeneration
- Impaired axonal maintenance
- Autophagy impairment
- Endosomal dysfunction
Dynein dysfunction is relevant to Parkinson's disease pathogenesis:
- Alpha-synuclein transport: Dynein mediates endosomal transport of alpha-synuclein
- LRRK2 interactions: LRRK2 mutations may affect dynein function
- Mitochondrial trafficking: Dynein transports mitochondria along axons
Dynein impairment exacerbates:
- Mitochondrial dysfunction
- Protein aggregation
- Dopaminergic neuron vulnerability in the substantia nigra
In ALS, dynein mutations have been identified that contribute to motor neuron degeneration:
- Dynactin mutations: Stabilize dynein function; mutations cause motor neuron disease
- Transport defects: Impaired organelle and protein transport
- Axonal degeneration: Reduced retrograde transport of survival signals
- TDP-43 pathology: Disrupts transport machinery
- Autophagy dysfunction: Impaired clearance of aggregates
FTD involves frontotemporal lobe degeneration with transport defects:
- Tau pathology: Disrupts microtubule networks used by dynein
- TDP-43 inclusions: May impair transport machinery
- Cargo accumulation: Accumulation of transport intermediates
DYNC2H1 alterations have been documented in:
- Huntington's Disease: Dynein function is impaired, contributing to transport deficits
- Charcot-Marie-Tooth Disease: Dynein mutations cause a subtype of this hereditary neuropathy
- Prion Diseases: Dynein-mediated transport is disrupted in prion-infected neurons
DYNC2H1 is expressed throughout the brain with high levels in:
- Cerebral cortex: High metabolic activity and long axons
- Hippocampus: Critical for memory formation
- Basal ganglia: Motor control centers
- Cerebellum: Motor coordination
- Substantia nigra: Dopaminergic neurons
- Spinal cord: Motor neurons
Within neurons:
- Cell body (soma): Primary location of dynein complex assembly
- Dendrites: Transport of synaptic proteins
- Axons: Long-distance retrograde transport
- Growth cones: Guidance during development and regeneration
- Synaptic terminals: Retrograde signaling
DYNC2H1 is expressed in various cell types:
- Epithelial cells (ciliated)
- Fibroblasts (primary cilia)
- Neuronal precursors
- Glial cells
| Interactor |
Function |
| DYNC2I1 |
Intermediate chain - cargo binding |
| DYNC2I2 |
Alternative intermediate chain |
| DYNC2LI1 |
Light intermediate chain |
| DYNC2LI2 |
Alternative light intermediate chain |
| DYNC1L1 |
Cytoplasmic dynein 1 - related complex |
| DCTN1 |
Dynactin - complex stabilizer |
- IFT-B complex subunits (anterograde coupling)
- IFT-A complex subunits (retrograde transport)
- IFT74/81 - Tubulin transport
- BBSome complex (ciliary trafficking)
- ROCK: Rho-kinase - phosphorylation regulation
- Lis1: Dynein regulator (lissencephaly)
- Ndel1: Neuronal dynein regulator
- BICD2: Dynactin binding protein
Modulating dynein function offers therapeutic potential:
- Enhancing retrograde transport: Improving survival signaling
- Restoring cargo delivery: Delivering synaptic proteins
- Reducing transport burden: Decreasing aggregate transport
- Autophagy enhancement: Improving aggregate clearance
- Dynein activators: Enhance motor function
- Microtubule stabilizers: Improve tracks for transport
- ATPase modulators: Enhance energy utilization
- Dynactin stabilizers: Improve complex function
- Viral vector delivery of functional DYNC2H1
- RNA-based approaches to restore expression
- CRISPR approaches for mutation correction
flowchart TD
A["DYNC2H1<br/>Dynein-2 Heavy Chain"] --> B["Motor Domain<br/>ATP Hydrolysis"]
B --> C["Microtubule<br/>Binding"]
C --> D["Minus-End<br/>Directed Movement"]
D --> E["Retrograde<br/>Transport"]
E --> F{"Cargo Types"}
F --> G["Signaling<br/>Endosomes"]
F --> H["Organelles<br/>and Vesicles"]
F --> I["Protein<br/>Aggregates"]
F --> J["Synaptic<br/>Components"]
G --> K["Cell Body<br/>Signaling"]
H --> L["Organelle<br/>Recycling"]
I --> M["Autophagy<br/>Pathway"]
J --> N["Somal<br/>Maintenance"]
K --> O["Neuronal<br/>Survival"]
L --> P["Cellular<br/>Homeostasis"]
M --> Q["Protein<br/>Quality Control"]
N --> R["Synaptic<br/>Function"]
S["Alzheimer's Disease"] -.-> T["Transport<br/>Impairment"]
U["Parkinson's Disease"] -.-> T
V["ALS"] -.-> T
T --> W["Neuronal<br/>Dysfunction"]
W --> X["Neurodegeneration"]
style A fill:#e1f5fe
style S fill:#ffcdd2
style U fill:#ffcdd2
style V fill:#ffcdd2
style X fill:#ef9a9a
DYNC2H1 mutations cause short rib-polydactyly syndrome type 3 (SRPS3), also known as Verma-Naumoff syndrome:
- Skeletal dysplasia
- Short ribs
- Polydactyly
- Often fatal in perinatal period
DYNC2H1 is one of several genes causing Jeune syndrome:
- Narrow thoracic cage
- Short ribs
- Respiratory distress
- Variable extrathoracic features
While not a primary cause, DYNC2H1 dysfunction contributes to:
- Alzheimer's disease progression
- Parkinson's disease pathogenesis
- Amyotrophic lateral sclerosis
- Frontotemporal dementia
- Charcot-Marie-Tooth disease
Key areas of ongoing research include:
- Mechanistic Studies: Understanding how DYNC2H1 dysfunction contributes to specific neurodegenerative disease processes
- Transport Kinetics: High-resolution studies of dynein movement along microtubules
- Cargo Adaptor Identification: Identifying the full repertoire of cargo adaptors
- Therapeutic Targeting: Developing small molecules that can modulate dynein function
- Axonal Transport Assays: Using live-cell imaging to monitor dynein-mediated transport
- iPSC Models: Using patient-derived neurons to study DYNC2H1 function